Josephine Bunch | |
---|---|
Alma mater | Sheffield Hallam University |
Scientific career | |
Institutions | National Physical Laboratory (United Kingdom) University of Sheffield |
Thesis | Detection and imaging of pharmaceutical compounds in skin by MALDI-MS (2005) |
Josephine Bunch is a fellow at the National Physical Laboratory. She is Chair of Biomolecular Mass Spectrometry at Imperial College London and the Co-Director of the National Centre of Excellence in Mass Spectrometry Imaging.
Bunch completed a PhD sponsored by Pfizer at Sheffield Hallam University in 2005.[1] Her thesis, "Detection and imaging of pharmaceutical compounds in skin by MALDI-MS", used mass spectrometry.[2]
Bunch was a postdoctoral researcher at the University of Sheffield, where she was awarded an Enterprise Fellowship to commercialise imaging using mass spectrometry.[1] She joined the University of Birmingham, leading a large multi-disciplinary group using MALDI Mass spectrometry.[3][4] She remains an honorary senior research fellow at the University of Birmingham.[5] She also holds a Chair in Biomolecular Mass Spectrometry at Imperial College London.[6]
She joined the National Physical Laboratory in 2013, where she became responsible for research in MALDI metrology.[4][7] In 2017 Bunch was funded by Cancer Research UK's Grand Challenge to map tumours at a molecular and cellular level.[8] She came up with the idea when listening to a BBC Radio 4 program about the Cancer Research UK Grand Challenges.[9] The investment was worth £16 million, and uses mass spectrometry imaging techniques to study breast, bowel and pancreatic tumours in "unprecedented detail.[10][11][12][13][14] She spoke about the project at the Hay Festival and presented their project at the Royal Society Summer Exhibition.[15][16][17]
She is part of a COST (European Cooperation in Science and Technology) Action on mass spectrometry imaging.[18][3]